BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/3/2025 6:15:35 AM | Browse: 18 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 109468
Country United Kingdom
Category Endocrinology & Metabolism
Manuscript Type Editorial
Article Title Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease
Manuscript Source Invited Manuscript
All Author List Cornelius J Fernandez, Sweekruti Jena, Vijaya Lakshmi and Joseph M Pappachan
Funding Agency and Grant Number
Corresponding Author Joseph M Pappachan, Academic Editor, FRCP, MD, MRCP, Professor, Senior Researcher, Faculty of Science, Manchester Metropolitan University, All Saints Building, Oxford Road, Manchester M15 6BH, United Kingdom. drpappachan@yahoo.co.in
Key Words Duodenal mucosal ablation; Endoscopic bariatric procedure; Type 2 diabetes mellitus; Metabolic and bariatric surgery; Obesity; Hepatic steatosis; Metabolic dysfunction-associated fatty liver disease
Core Tip Metabolic dysfunction-associated fatty liver disease is recognized as the most common cause of chronic liver disease globally with obesity being the prime driver for insulin resistance and hepatic steatosis. Though metabolic and bariatric surgery (MBS) is the most effective treatment option for severe obesity, it carries complication risks and long-term commitment to lifestyle adjustments. In the evolving landscape of obesity management, minimally invasive endoscopic bariatric therapies offer promising weight loss and metabolic benefits with lower complication rates compared to MBS. This editorial provides a comprehensive overview of various endoscopic bariatric techniques used in management of obesity and their effect on metabolic dysfunction-associated fatty liver disease which will help physicians to offer safer alternatives to conventional MBS.
Citation Fernandez CJ, Jena S, Lakshmi V, Pappachan JM. Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2025; In press
Received
2025-05-12 12:55
Peer-Review Started
2025-05-12 12:56
To Make the First Decision
Return for Revision
2025-05-26 20:39
Revised
2025-05-30 17:39
Second Decision
2025-07-03 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-07-03 06:15
Articles in Press
2025-07-03 06:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com